Statistics for Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial
Total visits
| views | |
|---|---|
| Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial | 2 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:f721b596-260b-4dd7-a32a-847c024213db | 54 |
| Battelino2021Dasiglucagon-CCBYNC.pdf | 22 |
| java.util.UUID:8da63ba0-d178-45e0-9b92-62225fe88265 | 19 |
| java.util.UUID:abba4cd6-a71b-44cd-89d9-dc81f064836e | 9 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Indianapolis | 2 |